SCHEMBL7184728

SCHEMBL7184728

CCCCOc1cccc(OCCCC)c1C=CC(=O)c1ccc(N)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 4/20 0.56
LMNA P02545 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49
TSHR P16473 1/20 0.49
CYP2C19 P33261 1/20 0.49
PDE4D Q08499 1/20 0.49
BCHE P06276 6/20 0.47
CYP1B1 Q16678 1/20 0.47
ACHE P22303 4/20 0.46
MAPT P10636 1/20 0.46
ATM Q13315 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
GAA P10253 1/20 0.46
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
KRAS P01116 1/20 0.45
DPP4 P27487 1/20 0.44
PTPN1 P18031 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7184853 0.94 ABCG2 (0.57) ABCG2LMNABCHECYP1B1MAPT
SCHEMBL7184476 0.88 ABCG2 (0.64) ABCG2LMNACYP1A2TSHRCYP2C19
SCHEMBL7187470 0.88 ABCG2 (0.60) ABCG2LMNACYP1A2BCHECYP1B1
SCHEMBL7187466 0.88 ABCG2 (0.60) ABCG2LMNACYP1A2BCHECYP1B1
SCHEMBL7180664 0.85 ABCG2 (0.46) ABCG2LMNACYP1A2CYP3A4CYP2C9
SCHEMBL7190647 0.85 ABCG2 (0.53) ABCG2LMNABCHEACHEMAPT
SCHEMBL7192480 0.85 ABCG2 (0.53) ABCG2LMNABCHEACHEMAPT
SCHEMBL7185283 0.83 ABCG2 (0.51) ABCG2LMNABCHEACHEMAPT
SCHEMBL7186727 0.83 ABCG2 (0.52) ABCG2BCHEACHEDPP4PTPN1
SCHEMBL7178891 0.83 ABCG2 (0.44) ABCG2LMNACYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed